EUVIMEDEUVIMED entdecken
Crossref

L26/P-107 The clinical impact of sperm DNA fragmentation on euploid embryo formation and live birth outcomes: a correlation with advanced paternal age

N. Aggarwal, S. Gupta

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.443 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von N. Aggarwal und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Does paternal age and sperm DNA fragmentation affect euploid embryo formation and live birth outcomes in ICSI–PGT-A cycles? Summary answer Higher sperm DNA fragmentation, especially in older fathers, significantly reduces euploid embryo yield, though implantation and live birth rates equalize once euploid embryos are transferred. What is known already Paternal aging is associated with increased sperm DNA instability, oxidative stress, and impaired chromatin packaging. Elevated sperm DNA fragmentation (DFI) has been linked to lower fertilization, poorer embryo development, and increased early pregnancy loss. Although PGT-A allows selection of euploid embryos, the influence of high DFI on euploid formation remains uncertain. Existing evidence suggests conflicting effects on clinical outcomes, and the independent predictive value of DFI in ICSI–PGT-A cycles is still debated. Understanding how paternal DNA integrity impacts euploid yield and live birth is critical for optimizing ART success and guiding male-focused interventions. Study design, size, duration This retrospective study analyzed 324 ICSI–PGT-A cycles performed between 2018–2024. Cycles were categorized by paternal age (<40 vs ≥ 40 years) and DFI (<30% vs ≥ 30%). Embryologic and clinical outcomes were compared, and multivariate logistic regression assessed predictors of euploid formation and live birth. The study evaluated how paternal genomic integrity influences outcomes across a six-year period in a high-volume ART center. Participants/materials, setting, methods Embryologic outcomes (fertilization, blastocyst formation, euploidy rate) and clinical outcomes (implantation, miscarriage, live birth) were assessed. ANOVA and chi-square tests compared groups; logistic regression controlled for maternal age and AMH to identify predictors of euploid embryos and live birth. All procedures were performed in a single high-volume ART laboratory following standardized protocols. Main results and the role of chance Men aged ≥40 years demonstrated significantly higher mean DFI (43.2% ± 6.5) compared with younger men (22.3% ± 4.2, p < 0.001). High DFI (≥30%) was associated with a marked reduction in euploid embryo rate (42.7% vs 61.5%, p = 0.002). Live birth rates were also significantly lower in the high-DFI group (36.1% vs 52.4%, p = 0.01). Regression analysis identified DFI ≥30% as an independent negative predictor for euploid embryo formation (OR = 0.56, 95% CI: 0.34–0.91), even after adjusting for maternal age and AMH. Fertilization, blastocyst formation, and clinical miscarriage rates showed no significant differences after controlling for euploidy. Importantly, once euploid embryos were transferred, implantation and live birth rates were similar across all DFI and paternal age groups (p > 0.05), suggesting the detrimental effect of DFI primarily occurs before embryo biopsy. These findings reduce the likelihood that observed differences occurred by chance, supported by consistent linear associations between advancing paternal age, increasing DFI, and reduced euploid yield. Limitations, reasons for caution Being retrospective, the study may be subject to selection bias and unmeasured confounders. DFI testing methods and lifestyle factors were not standardized. Findings apply only to ICSI–PGT-A cycles and may not generalize to non-PGT or natural conception contexts. Wider implications of the findings Routine DFI testing may help identify male partners at risk for reduced euploid embryo formation. Integrating antioxidant therapy, lifestyle modification, and advanced sperm selection could improve outcomes. Incorporating paternal genomic assessment may strengthen individualized ART planning. Trial registration number Yes

Zitieren

APA

Aggarwal, N., & Gupta, S. (2026). L26/P-107 The clinical impact of sperm DNA fragmentation on euploid embryo formation and live birth outcomes: a correlation with advanced paternal age. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.443

Vancouver

Aggarwal N, Gupta S. L26/P-107 The clinical impact of sperm DNA fragmentation on euploid embryo formation and live birth outcomes: a correlation with advanced paternal age. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.443

BibTeX
@article{Aggarwal2026,
  author = {Aggarwal, N. and Gupta, S.},
  title = {L26/P-107 The clinical impact of sperm DNA fragmentation on euploid embryo formation and live birth outcomes: a correlation with advanced paternal age},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.443}
}
Kostenlos starten →